References
- Strickley RG, Iwata Q, Wu S, Dahl TC. Pediatric drugs—a review of commercially available oral formulations. J Pharm Sci 2008;97:1731–74
- Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 2004;30:429–48
- Patel A, Vavia P. Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech 2008;9:544–50
- Funasaki N, Kawaguchi R, Hada S, Neya S. Ultraviolet spectroscopic estimation of microenvironments and bitter tastes of oxyphenonium bromide in cyclodextrin solutions. J Pharm Sci 1999;88:759–62
- Redenti E, Szente L, Szejtli J. Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci 2001;90:979–86
- Agarwal R, Mittal R, Singh A. Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev Ind Pharm 2000;26:773–6
- Cerea M, Zheng W, Young CR, McGinity JW. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm 2004;279:127–39
- Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 2007;8:127–33
- Xu J, Bovet LL, Zhao K. Taste masking microspheres for orally disintegrating tablets. Int J Pharm 2008;359:63–9
- Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Controlled Release 2009;139:94–107
- Athanikar NK, Chiou WL. Chlorpheniramine. II. Effect of the first-pass metabolism on the oral bioavailability in dogs. J Pharmacokinet Pharmacodyn 1979;7:383–96
- Park C, Kim J, Rhee Y, et al. Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet. Drug Dev Ind Pharm 2012;38:1179–87
- Mohanan D, Gander B, Kündig TM, Johansen P. Encapsulation of antigen in poly(d,l-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. Eur J Pharm Biopharm 2012;80:274–81
- O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliver Rev 1997;28:25–42
- Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Il Farmaco 2005;60:840–6
- Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282:1–18
- Kim K-S, Park S-J. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol. Colloids Surf B 2010;76:404–9
- Dillen K, Vandervoort J, Van den Mooter G, et al. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 2004;275:171–87
- Cilurzo F, Cupone IE, Minghetti P, et al. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 2008;70:895–900
- Cilurzo F, Cupone I, Minghetti P, et al. Nicotine fast dissolving films made of maltodextrins: a feasibility study. AAPS PharmSciTech 2010;11:1511–17
- Sugimoto M, Narisawa S, Matsubara K, et al. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method. Chem Pharm Bull 2006;54:175–80
- Cilurzo F, Cupone I, Minghetti P, et al. Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Dev Ind Pharm 2011;37:252–9
- Albertini B, Cavallari C, Passerini N, et al. Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer. Eur J Pharm Sci 2004;21:295–303
- Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci 1998;87:96–100
- Yu L. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008;25:781–91
- Wang YM, Sato H, Adachi I, Horikoshi I. Optimization of the formulation design of chitosan microspheres containing cisplatin. J Pharm Sci 1996;85:1204–10
- Fonner DE, Buck JR, Banker GS. Mathematical optimization techniques in drug product design and process analysis. J Pharm Sci 1970;59:1587–96
- Youm I, Murowchick JB, Youan B-BC. Entrapment and release kinetics of furosemide from pegylated nanocarriers. Colloids Surf B 2012;94:133–42
- Zhu W, Yu A, Wang W, et al. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 2008;360:184–90
- Fu H, Li H, Zhang F, et al. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro. Drug Dev Ind Pharm 2012;38:670–8
- Rao M, Borate S, Thanki K, et al. Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm 2009;35:834–42
- Shah S, Asghar S, Choudhry M, et al. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev Ind Pharm 2009;35:1470–8
- Sun Y, Peng Y, Chen Y, Shukla AJ. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliver Rev 2003;55:1201–15
- Takayama K, Fujikawa M, Obata Y, Morishita M. Neural network based optimization of drug formulations. Adv Drug Deliver Rev 2003;55:1217–31
- Xie H, Gan Y, Ma S, et al. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network. Drug Dev Ind Pharm 2008;34:363–72